Arsenic Trioxide, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia
Clinical trial NCT00093483 · COMPLETED
Trial details
- NCT number
- NCT00093483
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2009-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.